TrianglePUBLICATIONS · 25944303
Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2016 Jan
- First author
- Rosso DA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rosso DA
- type
- Author
- name
- Amaral D
- type
- Author
- name
- Latella A
- type
- Author
- name
- Chantada G
- type
- Author
- name
- Braier JL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rosso DA
- type
- Author
- name
- Amaral D
- type
- Author
- name
- Latella A
- type
- Author
- name
- Chantada G
- type
- Author
- name
- Braier JL
- type
- Author
- bibliography ids
- nci-bib-e54c9700bf831b2ed5589c4a
- book metadata
- content sha256
- 4556ddec2faa34c751185722b6aebd7a0556ed50e988f4b40996cf9959e00cb3
- document type
- citation
- dois
- 10.1111/bjh.13475
- electronic publication date
- display
- 2015 May 5
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25944303
- immutable id
- pubmed:25944303@4556ddec2faa34c751185722b6aebd7a0556ed50e988f4b40996cf9959e00cb3
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 2
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 287-90
- volume
- 172
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25944303
- provenance
- batch id
- 74265f1b641f04cf2d05
- provider
- NCBI PubMed ESummary
- record sha256
- 3f22a4faaaab86aa64fdc324c9ed73f7ea1fced90564f4ec6f29fbf921e18acd
- response sha256
- 193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
- retrieved at
- 2026-09-09T23:47:10.134322+00:00
- publication date
- display
- 2016 Jan
- precision
- month
- year
- 2016
- publication types
- Letter
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
Preserved source evidence · Not medical advice